Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout
Public ClinicalTrials.gov record NCT04875702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout: A Randomized Controlled Trial
Study identification
- NCT ID
- NCT04875702
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Massachusetts General Hospital
- Other
- Enrollment
- 650 participants
Conditions and interventions
Conditions
Interventions
- Allopurinol Drug
- Colchicine 0.6 mg Drug
- Colchicine 1.2 mg Drug
- Naproxen 250 MG Drug
- Naproxen 500 Mg Drug
- Prednisone 40 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 21, 2024
- Primary completion
- Aug 31, 2028
- Completion
- Oct 30, 2028
- Last update posted
- Sep 24, 2025
2024 – 2028
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| The University of Alabama at Birmingham | South Birmingham | Alabama | 35233 | Not yet recruiting |
| UCLA Health | Santa Monica | California | 90404 | Not yet recruiting |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Recruiting |
| Brigham and Women's Hospital (BWH) | Boston | Massachusetts | 02115 | Recruiting |
| Boston Medical Center (BMC) | Boston | Massachusetts | 02119 | Not yet recruiting |
| NYU Langone | New York | New York | 10010 | Recruiting |
| West Virginia University (Including Mobile Clinical Trials Unit) | Morgantown | West Virginia | 26506 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04875702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 24, 2025 · Synced May 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04875702 live on ClinicalTrials.gov.